These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
345 related articles for article (PubMed ID: 15884689)
1. The role of inflammation in acute coronary syndromes: review of the literature. Elhajj II; Haydar AA; Hujairi NM; Goldsmith DJ J Med Liban; 2004; 52(2):96-102. PubMed ID: 15884689 [TBL] [Abstract][Full Text] [Related]
2. Randomized comparison of the effects of ASA plus clopidogrel versus ASA alone on early platelet activation in acute coronary syndromes with elevated high-sensitivity C-reactive protein and soluble CD40 ligand levels. Vavuranakis M; Latsios G; Aggelis D; Bosinakou I; Karambelas I; Tousoulis D; Toutouzas K; Stefanadis C Clin Ther; 2006 Jun; 28(6):860-71. PubMed ID: 16860169 [TBL] [Abstract][Full Text] [Related]
3. Contemporary view of the acute coronary syndromes. Moustapha A; Anderson HV J Invasive Cardiol; 2003 Feb; 15(2):71-9. PubMed ID: 12556619 [No Abstract] [Full Text] [Related]
4. Relation between soluble intercellular adhesion molecule-1, statin therapy, and long-term risk of clinical cardiovascular events in patients with previous acute coronary syndrome (from PROVE IT-TIMI 22). Ray KK; Morrow DA; Shui A; Rifai N; Cannon CP Am J Cardiol; 2006 Oct; 98(7):861-5. PubMed ID: 16996863 [TBL] [Abstract][Full Text] [Related]
5. Atherosclerosis: an inflammatory disease. Liuzzo G Rays; 2001; 26(4):221-30. PubMed ID: 12696277 [TBL] [Abstract][Full Text] [Related]
6. Clinical and biochemical results of the metalloproteinase inhibition with subantimicrobial doses of doxycycline to prevent acute coronary syndromes (MIDAS) pilot trial. Brown DL; Desai KK; Vakili BA; Nouneh C; Lee HM; Golub LM Arterioscler Thromb Vasc Biol; 2004 Apr; 24(4):733-8. PubMed ID: 14962945 [TBL] [Abstract][Full Text] [Related]
7. Atherothrombosis in acute coronary syndromes: mechanisms, markers, and mediators of vulnerability. Wasserman EJ; Shipley NM Mt Sinai J Med; 2006 Jan; 73(1):431-9. PubMed ID: 16470323 [TBL] [Abstract][Full Text] [Related]
8. C-reactive protein and cardiovascular outcomes in smokers versus nonsmokers in non-ST-elevation acute coronary syndrome (from the TACTICS-TIMI 18 trial). Moghbeli N; Kirtane AJ; Ray KK; Murphy SA; Gibson CM; Braunwald E; Cannon CP; Am J Cardiol; 2005 Sep; 96(5):635-8. PubMed ID: 16125484 [TBL] [Abstract][Full Text] [Related]
9. [Inflammation markers in acute coronary syndrome]. Mirat J; Raguz M; Romić Z; Bergovec M; Raos V; Sikić-Vagić J; Bergovec M Acta Med Croatica; 2004; 58(2):115-7. PubMed ID: 15208795 [TBL] [Abstract][Full Text] [Related]
10. Interaction between inflammation and thrombosis in acute coronary syndrome. Lytvyn OI; Kopitsa MP; Petyunina OV Kardiol Pol; 2004 Aug; 61(8):110-6; discussion 114-6. PubMed ID: 15457277 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory markers as predictors of clinical outcome in acute coronary syndromes. Mulvihill NT; Boccalatte M; Foley JB Minerva Cardioangiol; 2002 Dec; 50(6):653-9. PubMed ID: 12473985 [TBL] [Abstract][Full Text] [Related]
13. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials. Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325 [TBL] [Abstract][Full Text] [Related]
14. The potential role of prasugrel in secondary prevention of ischemic events in patients with acute coronary syndromes. Toth PP Postgrad Med; 2009 Jan; 121(1):59-72. PubMed ID: 19179814 [TBL] [Abstract][Full Text] [Related]
15. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome. Chen YG; Xu F; Zhang Y; Ji QS; Sun Y; Lü RJ; Li RJ Chin Med J (Engl); 2006 Jan; 119(1):32-6. PubMed ID: 16454979 [TBL] [Abstract][Full Text] [Related]
16. Circulating soluble adhesion molecules ICAM-1 and VCAM-1 and their association with clinical outcome, troponin T and C-reactive protein in patients with acute coronary syndromes. Postadzhiyan AS; Tzontcheva AV; Kehayov I; Finkov B Clin Biochem; 2008 Feb; 41(3):126-33. PubMed ID: 18061588 [TBL] [Abstract][Full Text] [Related]
17. [Inflammation, atherosclerosis and acute coronary syndromes]. Biasucci LM; Santamaria M; Liuzzo G Minerva Cardioangiol; 2002 Oct; 50(5):475-86. PubMed ID: 12384630 [TBL] [Abstract][Full Text] [Related]
18. The clinical importance of laboratory-defined aspirin resistance in patients presenting with non-ST elevation acute coronary syndromes. Acikel S; Yildirir A; Aydinalp A; Bal U; Kaynar G; Ozin B; Muderrisoglu H Blood Coagul Fibrinolysis; 2009 Sep; 20(6):427-32. PubMed ID: 19542882 [TBL] [Abstract][Full Text] [Related]
19. The year in non-ST-segment elevation acute coronary syndromes. Giugliano RP; Braunwald E J Am Coll Cardiol; 2005 Sep; 46(5):906-19. PubMed ID: 16139143 [No Abstract] [Full Text] [Related]
20. [Use of assessment of aggregation of thrombocytes induced by cationic propyl gallate to estimate recurrence of cardiovascular complications]. Stejskal D; Prosková J; Lacnák B; Horalík D; Hamplová A; Oral I; Hrabovská I; Ochmanová R; Adamovská S; Juráková R; Ozanová G; Juchelka J; Kulísková O; Pĕnkavová H Vnitr Lek; 2004 Aug; 50(8):591-9. PubMed ID: 15521202 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]